If you stop taking your medication and then restart it, you may experience side effects similar to what you experienced when you first started taking it
For researchers interested in how semaglutide compares to other GLP-1 receptor agonists, our semaglutide vs tirzepatide comparison breaks down the differences in receptor activity, efficacy data, and dosing protocols
[21] [22] Recognizing electrolyte imbalance early allows for prompt intervention before serious complications develop
Its satiety effect is mediated by receptors expressed in the area postrema, which relay signals to other structures involved in appetite regulation, such as the nucleus of the solitary tract, the lateral parabrachial nucleus, the ventral tegmental area, and the arcuate nucleus in the hypothalamus.57 Some of amylins actions are mediated through interaction with calcitonin gene-related peptide (CGRP) receptors, which is why it is considered a dual amylincalcitonin receptor agonist (DACRA).57 Cagrilintide is a long-acting DACRA that has been evaluated both as monotherapy and in combination with semaglutide (CagriSema) for body weight management in individuals with overweight or obesity, achieving a weight reduction of 17.1% over 20 weeks with the maximum weekly doses of both peptides (2.4 mg each).58 It has also proven effective in individuals with obesity and type 2 diabetes, although the weight reduction observed in this group was lower
It also increases bone mineral content, production of IGF-1 and insulin or muscle growth
